Our patients

We are committed to putting patient needs first and have an outstanding reputation in providing effective medicines for the treatment of:

• Chronic obstructive pulmonary disease (COPD): affects nearly a million people in the UK.
• Heart attack (Myocardial Infarction): causes around 180,000 hospital admissions in the UK each year.
• Secondary stroke prevention: Each year about 110,000 people in the UK have a first stroke, and about 30,000 have a recurrent stroke. Strokes cause over 53,000 deaths every year in the UK.
• Thromboembolic disease: annually kills more people in the UK than the total combined number of deaths from breast cancer, prostate cancer, AIDS and traffic accidents.
• High blood pressure: 1 in 4 middle aged adults in the UK has high blood pressure.
• HIV/AIDS: an estimated 83,000 are living with this disease in the UK.
• Parkinson’s: affects 1 person per 500 in the UK (a total of around 120,000).

In the above areas we have met medical needs and improved the lives of patients. For the future we are developing new medicines to treat patients suffering from:

• Stroke due to atrial fibrillation (abnormal heart rhythm): atrial fibrillation affects more than half a million people in the UK and is a leading cause of stroke.
• Diabetes: over 2.6 million people suffer from diabetes in the UK and up to half a million people with diabetes have the condition and don’t know it.
• Oncology: 1 in 3 people in the UK develop cancer during their lives.